Rotavirus infection represents one of the most common causes of diarrhea in young pigs worldwide, affecting swine populations across all production systems and geographic regions. These double-stranded RNA viruses belong to the family Reoviridae and cause acute gastroenteritis characterized by villous atrophy and malabsorptive diarrhea. Porcine rotaviruses are classified into multiple groups, with Group A rotaviruses being the most prevalent and clinically significant, though Groups B and C also circulate in swine populations. The ubiquitous nature of rotavirus in the swine environment means that virtually all pigs encounter this pathogen during their early life, making complete prevention essentially impossible while effective management remains critically important.
Rotavirus primarily affects young pigs between one and eight weeks of age, with peak susceptibility occurring during the nursing and early post-weaning periods. Neonatal piglets in their first few days of life receive protection from maternal antibodies obtained through colostrum, which partially shields them during the most vulnerable period. As maternal immunity wanes during the second and third weeks of life, piglets become increasingly susceptible to clinical rotavirus infection. The stress of weaning, combined with the decline in passive protection and introduction to new environmental challenges, creates a particularly high-risk period for rotavirus-associated diarrhea in recently weaned pigs. Older growing pigs and adults typically experience subclinical infections that contribute to population immunity.
While rotavirus infection is generally considered less severe than other causes of porcine enteric disease such as transmissible gastroenteritis or porcine epidemic diarrhea, its economic impact should not be underestimated. The high prevalence of infection means that most swine operations experience some degree of rotavirus-associated morbidity annually. Growth setbacks in affected piglets, increased medication costs for supportive care and secondary infection control, and labor demands for managing sick animals contribute to production losses. In operations with poor environmental conditions or concurrent disease challenges, rotavirus mortality can reach significant levels. The cumulative economic burden across the global swine industry represents substantial annual losses.
Effective rotavirus management requires understanding the interplay between viral exposure, host immunity, and environmental factors that determine clinical outcomes. While the self-limiting nature of most infections means that affected pigs typically recover with minimal intervention, proactive management can reduce disease severity and prevent the welfare and performance impacts associated with clinical illness. Strategies combining maternal immunity optimization through sow vaccination or exposure management, environmental sanitation, and prompt supportive care for affected piglets enable producers to minimize rotavirus impact while accepting that complete elimination is neither practical nor necessary.
